"Mount Sinai Researchers Receive NIH Award To Develop Universal Flu Vaccine"
Researchers at the Icahn School of Medicine at Mount Sinai have received a contract award of up to $132 million from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, as part of a new Collaborative Influenza Vaccine Innovation Centers program to further develop the universal flu vaccine. According to co-principal investigator to Florian Krammer, PhD, professor of microbiology at the Icahn School of Medicine at Mount Sinai, “The influenza virus is constantly changing each year, and spreads readily from person to person. With each new strain comes a new formulation that we hope will match and protect against that strain. If we are successful, and I know we will be, we will develop a vaccine that provides universal protections against each new strain. I am confident we will get there."
— Florian Krammer, PhD, Associate Professor, Microbiology, Icahn School of Medicine at Mount Sinai
Additional coverage: National Institutes of Health; Bioengineer;Science Magazine
